tiprankstipranks
Trending News
More News >
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
US Market

REPRO-MED Systems (KRMD) Stock Statistics & Valuation Metrics

Compare
282 Followers

Total Valuation

REPRO-MED Systems has a market cap or net worth of $106.04M. The enterprise value is $120.61M.
Market Cap$106.04M
Enterprise Value$120.61M

Share Statistics

REPRO-MED Systems has 46.10M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46.10M
Owened by Insiders17.16%
Owened by Instutions28.57%

Financial Efficiency

REPRO-MED Systems’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -27.06%.
Return on Equity (ROE)-36.08%
Return on Assets (ROA)-22.29%
Return on Invested Capital (ROIC)-27.06%
Return on Capital Employed (ROCE)-27.77%
Revenue Per Employee$420,580.788
Profits Per Employee-$75,832.913
Employee Count80
Asset Turnover1.24
Inventory Turnover4.39

Valuation Ratios

The current PE Ratio of REPRO-MED Systems is -29.07. REPRO-MED Systems’s PEG ratio is 0.51.
PE Ratio-29.07
PS Ratio5.24
PB Ratio10.49
Price to Fair Value10.49
Price to FCF-109.04
Price to Operating Cash Flow-551.55
PEG Ratio0.51

Income Statement

In the last 12 months, REPRO-MED Systems had revenue of $33.65M and earned -$6.07M in profits. Earnings per share was -$0.09.
Revenue$33.65M
Gross Profit$21.10M
Operating Income-$6.45M
Pretax Income-$6.06M
Net Income-$6.07M
EBITDA-5.56M
Earnings Per Share (EPS)-0.09

Cash Flow

In the last 12 months, operating cash flow was -$319.72K and capital expenditures -$1.30M, giving a free cash flow of -$1.62M billion.
Operating Cash Flow-$319.72K
Free Cash Flow-$1.62M
Free Cash Flow per Share-$0.04

Dividends & Yields

REPRO-MED Systems pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-0.92%
Earnings Yield-3.44%

Stock Price Statistics

Beta0.69
52-Week Price Change10.58%
50-Day Moving Average3.33
200-Day Moving Average3.09
Relative Strength Index (RSI)27.54
Average Volume (3m)187.87K

Important Dates

REPRO-MED Systems upcoming earnings date is Apr 30, 2025, After Close.
Last Earnings DateMar 12, 2025
Next Earnings DateApr 30, 2025
Ex-Dividend Date

Financial Position

REPRO-MED Systems as a current ratio of 2.66, with Debt / Equity ratio of 0.22
Current Ratio2.66
Quick Ratio2.27
Debt to Market Cap0.02
Net Debt to EBITDA1.05
Interest Coverage Ratio0.00

Taxes

In the past 12 months, REPRO-MED Systems has paid $190.99K in taxes.
Income Tax$190.99K
Effective Tax Rate0.05%

Enterprise Valuation

REPRO-MED Systems EV to EBITDA ratio is -30.67, with an EV/FCF ratio of -105.42.
EV to Sales5.07
EV to EBITDA-30.67
EV to Free Cash Flow-105.42
EV to Operating Cash Flow-533.21

Balance Sheet

REPRO-MED Systems has $9.58M in cash and marketable securities with $3.72M in debt, giving a net cash position of -$5.86M billion.
Cash & Marketable Securities$9.58M
Total Debt$3.72M
Net Cash-$5.86M
Net Cash Per Share-$0.13
Tangible Book Value Per Share$0.35

Margins

Gross margin is 63.40%, with operating margin of -16.52%, and net profit margin of -18.03%.
Gross Margin63.40%
Operating Margin-16.52%
Pretax Margin-18.04%
Net Profit Margin-18.03%
EBITDA Margin-16.52%
EBIT Margin-19.16%

Analyst Forecast

The average price target for REPRO-MED Systems is $5.17, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$5.17
Price Target Upside124.78%
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast17.98%
EPS Growth Forecast56.04%

Scores

Smart Score5
AI Score51
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis